Maxar Technologies partners with Intelsat to build Intelsat 40e

By Nikita Chaurasia  Date: 2020-02-04

Maxar Technologies partners with Intelsat to build Intelsat 40e

Space tech company, Maxar Technologies Inc. has recently been selected as a trusted partner and innovator in space infrastructure and earth intelligence by satellite telecommunications firm Intelsat Corp.

Reportedly, under this partnership, Maxar would help Intelsat in building a next-generation geostationary communications satellite dubbed Intelsat 40e which is planned to launch in 2022. Apparently, Maxar would incorporate Intelsat 40e satellite with NASA’s Tropospheric Emissions: Monitoring of Pollution (TEMPO) payload.

Earlier in 2019, NASA had chosen Maxar to host its TEMPO payload using SMC’s (Space and Missile Systems Center) HoPS contract vehicle. TEMPO is a UV-visible spectrometer that detects pollutants with the help of sunlight scattered and reflected from the atmosphere and earth’s surface.

Reportedly, TEMPO’s resulting data would be exercised to improve air-quality forecasts in North America, allowing regulators to provide early public warning of pollution incidents more effectively. The combined TEMPO and Intelsat 40e programs are also projected to be lucrative for Maxar’s cash flow and earnings on an annual basis.

Based on Intelsat Epic and Maxar’s 1300-class satellite platform, Intelsat 40e would offer its North and Central American customers with high-throughput, flexible “coast-to-coast” coverage. Moreover, the extra capacity would further support increasing number of users employing Intelsat managed-service solutions for their day-to-day tasks, which include people using Intelsat to solve connectivity issues for private and commercial aircraft and automobiles.

Speaking on the development, Stephen Spengler, CEO, Intelsat, said that after its launch, Intelsat 40e would be added to its next-gen Intelsat Epic platform, which is well known for offering flexible, high-performance connectivity to its global customers.

Moreover, Intelsat constantly invests in new and advanced hybrid technologies and satellites that help connecting devices, networks and people with most remote locations easy and affordable. The company is looking forward to working with Maxar on this next new project, added Spengler.

Source Credit: http://investor.maxar.com/investor-news/press-release-details/2020/Maxar-Technologies-Will-Build-Next-Generation-Intelsat-Epic-Geostationary-Communications-Satellite-with-NASA-Hosted-Payload/default.aspx

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...